Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04230681
Other study ID # 201912042
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date February 26, 2020
Est. completion date April 1, 2022

Study information

Verified date March 2023
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A RCT to compare hydromorphone versus fentanyl for pain control following tonsillectomy or adenotonsillectomy surgery.


Description:

This is a randomized clinical trial with masked assessment, comparing recovery indices for patients receiving intermediate acting versus short acting opioid analgesia using hydromorphone or fentanyl as intraoperative analgesics. An otherwise standardized anesthetic and analgesic regimen will be utilized, consistent with routine care at SLCH. Patients will be randomized 1:1 in block sizes of 5 per group. Patients will be randomized to receive either hydromorphone or fentanyl throughout the perioperative period by opening a sealed protocol envelope.


Recruitment information / eligibility

Status Completed
Enrollment 189
Est. completion date April 1, 2022
Est. primary completion date April 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 15 Years
Eligibility Inclusion Criteria: 1. Children ages 2 to 15 years old 2. Presenting for tonsillectomy or adenotonsillectomy surgery 3. American Society of Anesthesiologists Physical Status (ASAPS) Classification 1, 2 or 3 4. Provide Informed Consent / Assent (as appropriate) Exclusion Criteria: 1. Additional Concurrent surgeries, exclusive of myringotomy tubes, minor oral/nasal procedures (e.g. frenulectomy), and endoscopic procedures 2. Revision tonsillectomy or revision adenotonsillectomy surgery 3. Known pregnancy 4. Any condition which would make the participant, in the opinion of the investigator or the attending anesthesiologist caring for the patient, unsuitable for the study.

Study Design


Intervention

Drug:
Hydromorphone
Patients will be randomized to one of two opioids for the treatment of post-operative pain.
Fentanyl
Fentanyl

Locations

Country Name City State
United States Washington University School of Medicine/Barnes-Jewish Hospital Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

References & Publications (3)

Bhattacharyya N, Lin HW. Changes and consistencies in the epidemiology of pediatric adenotonsillar surgery, 1996-2006. Otolaryngol Head Neck Surg. 2010 Nov;143(5):680-4. doi: 10.1016/j.otohns.2010.06.918. — View Citation

Brown KA. Outcome, risk, and error and the child with obstructive sleep apnea. Paediatr Anaesth. 2011 Jul;21(7):771-80. doi: 10.1111/j.1460-9592.2011.03597.x. Epub 2011 May 3. — View Citation

Friedman NR, Perkins JN, McNair B, Mitchell RB. Current practice patterns for sleep-disordered breathing in children. Laryngoscope. 2013 Apr;123(4):1055-8. doi: 10.1002/lary.23709. Epub 2013 Feb 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of rescue opioid medications administered - hydromorphone group Postoperative opioid medication expressed in morphine equivalents up to 48 hours post surgery
Primary Amount of rescue opioid medications administered - fentanyl group Postoperative opioid medication expressed in morphine equivalents up to 48 hours post surgery
Primary Evaluation of participant's pain - hydromorphone group Revised Face, Legs, Activity, Cry, Consolability (rFLACC) Scale Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability is scored from 0-2, which results in a total score between zero and ten. 0=no pain/relaxed, 10=distressed/in pain up to 48 hours post surgery
Primary Evaluation of participant's pain - fentanyl group Revised Face, Legs, Activity, Cry, Consolability (rFLACC) Scale Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability is scored from 0-2, which results in a total score between zero and ten. 0=no pain/relaxed, 10=distressed/in pain up to 48 hours post surgery
Secondary Preoperative Amsterdam Preoperative Anxiety Scale - hydromorphone group Caregiver of the participant is asked questions regarding the child's anxiety level prior to surgery. The questions asked: 1) I am worried about the anesthetic, 2) The anesthetic is on my mind continually, 3) I would like to know as much as possible about the anesthetic, 4) I am worried about the procedure, 5) The procedure is on my mind continually, 6) I would like to know as much as possible about the procedure
The measure of agreement with these statements should be graded on a 5-point Likert scale from 1 "not at all" to 5 "extremely." A score of =11 identify anxious patients in clinical practice.
up to 12 hours prior to surgery
Secondary Preoperative Amsterdam Preoperative Anxiety Scale - fentanyl group Caregiver of the participant is asked questions regarding the child's anxiety level prior to surgery. The questions asked: 1) I am worried about the anesthetic, 2) The anesthetic is on my mind continually, 3) I would like to know as much as possible about the anesthetic, 4) I am worried about the procedure, 5) The procedure is on my mind continually, 6) I would like to know as much as possible about the procedure
The measure of agreement with these statements should be graded on a 5-point Likert scale from 1 "not at all" to 5 "extremely." A score of =11 identify anxious patients in clinical practice.
up to 12 hours prior to surgery
Secondary Yale Preoperative Anxiety Scale - hydromorphone group Assessing child anxiety during the induction of anesthesia. It contains 22 items in 5 categories: activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each category receives a score on a scale of 0 to 4 (6 for vocalization) according to the behavior of the patient, with 0 = no anxiety and 4 (or 6 for vocalization) = high anxiety. up to 12 hours prior to surgery
Secondary Yale Preoperative Anxiety Scale - fentanyl group Assessing child anxiety during the induction of anesthesia. It contains 22 items in 5 categories: activity, emotional expressivity, state of arousal, vocalization, and use of parents. Each category receives a score on a scale of 0 to 4 (6 for vocalization) according to the behavior of the patient, with 0 = no anxiety and 4 (or 6 for vocalization) = high anxiety. up to 12 hours prior to surgery
Secondary ASA physical status classification score from preoperative assessment - hydromorphone group ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes up to 12 hours prior to surgery
Secondary ASA physical status classification score from preoperative assessment - fentanyl group ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes up to 12 hours prior to surgery
Secondary Optional opioid plasma concentrations - hydromorphone group Blood collection at three time points using mass spectroscopy (This is optional for participants) up to 48 hours after surgery
Secondary Optional opioid plasma concentrations - fentanyl group Blood collection at three time points using mass spectroscopy (This is optional for participants) up to 48 hours after surgery
Secondary Adverse events - hydromorphone group Nausea/vomiting, witnessed apneic events, desaturation events, respiratory depression, re-intubation, decreased oxygen saturation up to 48 hours after surgery
Secondary Adverse events - fentanyl group Nausea/vomiting, witnessed apneic events, desaturation events, respiratory depression, re-intubation, decreased oxygen saturation up to 48 hours after surgery
Secondary NIH PROMIS - hydromorphone group Patient satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always up to 48 hours after surgery
Secondary NIH PROMIS - fentanyl group Patient satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always up to 48 hours after surgery
Secondary NIH PROMIS - hydromorphone group Patient caregiver satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always up to 48 hours after surgery
Secondary NIH PROMIS - fentanyl group Patient caregiver satisfaction, behavior and pain scores over past 7 days. Scale of 1 - 6, with 1=had no pain and 6=almost always up to 48 hours after surgery
Secondary Child Hospital Survey (CAHPS) - hydromorphone group Patient caregiver satisfaction. Scale of 1 - 4 with 1=never and 6=always up to 48 hours after surgery
Secondary Child Hospital Survey (CAHPS) - fentanyl group Patient caregiver satisfaction. Scale of 1 - 4 with 1=never and 6=always up to 48 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A